Trademarkia Logo

Australia

AU$
LYTENAVA
Protected: Registered/protected

Last updated on 26 May 2025

Owner Info

Outlook Therapeutics, Inc.

7 Clarke Drive

Cranbury NJ 08512, UNITED STATES OF AMERICA

Serial Number

2133787 filed on 1 Oct 2020

Correspondent

Ariana G. Hiscott Cooley LLP

1299 Pennsylvania Avenue, NW, Suite 700,

Washington DC 20004-2400,

UNITED STATES OF AMERICA

LYTENAVA

Classification Information


Class [005]
Injectable pharmaceutical preparations for the treatment of retinal disease; pharmaceuticals, namely, ophthalmic drugs for the treatment of retinal di Read More

Mark Details


Serial Number

2133787

Registered On

1 Oct 2020

Renewal On

1 Oct 2030

Mark Type

WORD

Priority Claim (Convention Details)


Date

14 Apr 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
26th May 2025Amendment to Address for Service Requested
26th May 2025Transformation of Australian Trade Mark Requested
4th Feb 2021International Registration in Australia Protected correspondence sent
3rd Feb 2021IP Right Registration Published
3rd Feb 2021Status change to Registered/Protected
27th Nov 2020Application Accepted correspondence sent
26th Nov 2020IP Right has been Examined
26th Nov 2020IP Right Acceptance Published
26th Nov 2020Status change to Accepted
5th Nov 2020Examination expedited